![Kathy Goetz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/06/2026
Kathy L.
Goetz is currently Director at abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, abrdn World Healthcare Fund, Aberdeen Investments LLC, and will be Director at Aurinia Pharmaceuticals, Inc. starting in 2025.
Former roles include Vice President & Head-Sales at Novartis AG from 2007 to 2019 and Vice President & Head-Sales at Novartis Pharmaceuticals AG.
Education includes undergraduate studies at Iowa State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 15/05/2025 |
| ABRDN WORLD HEALTHCARE FUND | Direttore/Membro del Consiglio | - |
| ABRDN HEALTHCARE OPPORTUNITIES FUND | Direttore/Membro del Consiglio | - |
| ABRDN LIFE SCIENCES INVESTORS | Direttore/Membro del Consiglio | - |
| ABRDN HEALTHCARE INVESTORS | Direttore/Membro del Consiglio | - |
Aberdeen Investments LLC
 Aberdeen Investments LLC Financial ConglomeratesFinance Provides investment services | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| NOVARTIS AG | Vendite & Marketing | 01/01/2019 |
Novartis Pharmaceuticals AG | Vendite & Marketing | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
abrdn Healthcare Investors
 abrdn Healthcare Investors Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
abrdn Life Sciences Investors
 abrdn Life Sciences Investors Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
abrdn World Healthcare Fund
 abrdn World Healthcare Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Iowa State University
 Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Novartis Pharmaceuticals AG | |
Aberdeen Investments LLC
Aberdeen Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
